NVO logo

Novo Nordisk A/S (NVO) Interest expense

annual interest expense:

$237.95M+$159.25M(+202.38%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual interest expense is $237.95 million, with the most recent change of +$159.25 million (+202.38%) on December 31, 2024.
  • During the last 3 years, NVO annual interest expense has risen by +$191.96 million (+417.43%).
  • NVO annual interest expense is now at all-time high.

Performance

NVO Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

quarterly interest expense:

$730.72M+$818.31M(+934.25%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly interest expense is $730.72 million, with the most recent change of +$818.31 million (+934.25%) on March 31, 2025.
  • Over the past year, NVO quarterly interest expense has increased by +$428.63 million (+141.89%).
  • NVO quarterly interest expense is now at all-time high.

Performance

NVO quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

TTM interest expense:

$989.59M+$428.63M(+76.41%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO TTM interest expense is $989.59 million, with the most recent change of +$428.63 million (+76.41%) on March 31, 2025.
  • Over the past year, NVO TTM interest expense has increased by +$633.04 million (+177.55%).
  • NVO TTM interest expense is now at all-time high.

Performance

NVO TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

NVO Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+202.4%+141.9%+177.6%
3 y3 years+417.4%+236.8%+557.3%
5 y5 years+621.3%+281.3%+1218.5%

NVO Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+417.4%at high+166.1%at high+269.1%
5 y5-yearat high+621.3%at high+166.1%at high+269.1%
alltimeall timeat high+3320.7%at high+166.1%at high+245.2%

NVO Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$730.72M(-934.3%)
$989.59M(+76.4%)
Dec 2024
$237.95M(+202.4%)
-$87.59M(-172.4%)
$560.96M(+62.4%)
Sep 2024
-
$120.99M(-46.3%)
$345.33M(-36.2%)
Jun 2024
-
$225.47M(-25.4%)
$540.94M(+51.7%)
Mar 2024
-
$302.09M(-199.6%)
$356.54M(+64.9%)
Dec 2023
$78.69M(+46.9%)
-$303.22M(-195.8%)
$216.26M(-136.9%)
Sep 2023
-
$316.60M(+670.9%)
-$585.37M(+47.2%)
Jun 2023
-
$41.07M(-74.6%)
-$397.67M(-1582.8%)
Mar 2023
-
$161.81M(-114.6%)
$26.82M(-67.3%)
Dec 2022
$53.59M(+16.5%)
-$1.10B(-319.1%)
$81.94M(-91.6%)
Sep 2022
-
$504.30M(+8.3%)
$973.45M(+58.0%)
Jun 2022
-
$465.56M(+114.6%)
$616.11M(+309.2%)
Mar 2022
-
$216.92M(-201.7%)
$150.56M(+139.6%)
Dec 2021
$45.99M(-23.0%)
-$213.34M(-245.2%)
$62.83M(+2076.2%)
Sep 2021
-
$146.97M(+13.8%)
$2.89M(-112.2%)
Mar 2021
-
$129.20M(-147.3%)
-$23.60M(-160.8%)
Dec 2020
$59.76M(+81.1%)
-$273.28M(-723.5%)
$38.82M(-130.6%)
Sep 2020
-
$43.83M(-42.8%)
-$126.85M(+168.8%)
Jun 2020
-
$76.65M(-60.0%)
-$47.19M(-162.9%)
Mar 2020
-
$191.62M(-143.7%)
$75.06M(+86.8%)
Dec 2019
$32.99M(+145.0%)
-$438.95M(-455.4%)
$40.19M(-85.7%)
Sep 2019
-
$123.49M(-37.9%)
$281.32M(+6.9%)
Jun 2019
-
$198.89M(+26.9%)
$263.08M(+43.3%)
Mar 2019
-
$156.76M(-179.2%)
$183.56M(+457.8%)
Dec 2018
$13.46M(-1.7%)
-$197.83M(-287.9%)
$32.91M(-162.3%)
Sep 2018
-
$105.26M(-11.8%)
-$52.81M(-66.6%)
Jun 2018
-
$119.37M(+1855.7%)
-$158.07M(+50.1%)
Mar 2018
-
$6.10M(-102.2%)
-$105.34M(+2069.4%)
Dec 2017
$13.70M(+41.8%)
-$283.55M(-264.7%)
-$4.86M(-102.1%)
Jun 2017
-
$172.11M(+61.5%)
$235.93M(+269.7%)
Mar 2017
-
$106.58M(-275.9%)
$63.82M(+381.0%)
Dec 2016
$9.66M
-$60.61M(-439.7%)
$13.27M(-101.9%)
DateAnnualQuarterlyTTM
Sep 2016
-
$17.84M(-68.2%)
-$681.35M(+397.8%)
Mar 2016
-
$56.03M(-107.4%)
-$136.87M(-335.7%)
Dec 2015
$9.97M(+43.3%)
-$755.22M(-373.7%)
$58.06M(-91.3%)
Sep 2015
-
$275.95M(-3.6%)
$668.98M(+41.9%)
Jun 2015
-
$286.37M(+14.1%)
$471.44M(+123.6%)
Mar 2015
-
$250.97M(-273.9%)
$210.80M(+1057.6%)
Dec 2014
$6.96M(-29.0%)
-$144.31M(-284.0%)
$18.21M(-78.3%)
Sep 2014
-
$78.42M(+204.8%)
$83.87M(+233.1%)
Jun 2014
-
$25.73M(-55.9%)
$25.18M(-45.5%)
Mar 2014
-
$58.38M(-174.2%)
$46.23M(+564.0%)
Dec 2013
$9.79M(-2.2%)
-$78.65M(-498.7%)
$6.96M(-103.6%)
Sep 2013
-
$19.73M(-57.8%)
-$191.39M(+51.5%)
Jun 2013
-
$46.77M(+144.7%)
-$126.33M(+399.4%)
Mar 2013
-
$19.11M(-106.9%)
-$25.30M(-216.5%)
Dec 2012
$10.02M(-80.5%)
-$277.00M(-426.7%)
$21.71M(-90.3%)
Sep 2012
-
$84.78M(-42.6%)
$224.11M(+13.3%)
Jun 2012
-
$147.81M(+123.5%)
$197.75M(+140.7%)
Mar 2012
-
$66.12M(-188.6%)
$82.17M(+49.6%)
Dec 2011
$51.37M(-42.3%)
-$74.60M(-227.7%)
$54.94M(-947.9%)
Sep 2011
-
$58.42M(+81.3%)
-$6.48M(-136.4%)
Jun 2011
-
$32.23M(-17.1%)
$17.79M(-78.8%)
Mar 2011
-
$38.90M(-128.6%)
$83.79M(+3.2%)
Dec 2010
$89.01M(-62.4%)
-$136.02M(-264.5%)
$81.16M(-70.3%)
Sep 2010
-
$82.69M(-15.8%)
$273.33M(+18.4%)
Jun 2010
-
$98.23M(+170.9%)
$230.79M(+16.2%)
Mar 2010
-
$36.26M(-35.4%)
$198.62M(-15.3%)
Dec 2009
$236.74M
$56.16M(+39.9%)
$234.56M(+31.5%)
Sep 2009
-
$40.15M(-39.2%)
$178.41M(+17.7%)
Jun 2009
-
$66.06M(-8.5%)
$151.54M(+77.3%)
Mar 2009
-
$72.20M(+443.6%)
$85.48M(-2.0%)
Sep 2008
-
$13.28M(-82.0%)
$87.25M(+18.0%)
Mar 2008
-
$73.97M
$73.97M

FAQ

  • What is Novo Nordisk A/S annual interest expense?
  • What is the all time high annual interest expense for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual interest expense year-on-year change?
  • What is Novo Nordisk A/S quarterly interest expense?
  • What is the all time high quarterly interest expense for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly interest expense year-on-year change?
  • What is Novo Nordisk A/S TTM interest expense?
  • What is the all time high TTM interest expense for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM interest expense year-on-year change?

What is Novo Nordisk A/S annual interest expense?

The current annual interest expense of NVO is $237.95M

What is the all time high annual interest expense for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual interest expense is $237.95M

What is Novo Nordisk A/S annual interest expense year-on-year change?

Over the past year, NVO annual interest expense has changed by +$159.25M (+202.38%)

What is Novo Nordisk A/S quarterly interest expense?

The current quarterly interest expense of NVO is $730.72M

What is the all time high quarterly interest expense for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly interest expense is $730.72M

What is Novo Nordisk A/S quarterly interest expense year-on-year change?

Over the past year, NVO quarterly interest expense has changed by +$428.63M (+141.89%)

What is Novo Nordisk A/S TTM interest expense?

The current TTM interest expense of NVO is $989.59M

What is the all time high TTM interest expense for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM interest expense is $989.59M

What is Novo Nordisk A/S TTM interest expense year-on-year change?

Over the past year, NVO TTM interest expense has changed by +$633.04M (+177.55%)
On this page